Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-049681

President and CEO sold 29,022 shares at an average $20.43 ($592,812)

  • President and CEO acquired 29,022 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fordyce Marshall · President and CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-09 Exercise or conversion : show line 1 in the form +12,886 $2.90 $37,328 194,036 D
2022-09-09 Sale : show line 2 in the form −12,886 $20.16 $259,771 181,150 D
2022-09-12 Exercise or conversion : show line 3 in the form +12,821 $2.90 $37,140 193,971 D
2022-09-12 Sale : show line 4 in the form −12,821 $20.53 $263,195 181,150 D
2022-09-12 Exercise or conversion : show line 5 in the form +3,315 $2.90 $9,603 184,465 D
2022-09-12 Sale : show line 6 in the form −3,315 $21.07 $69,846 181,150 D
Open-market sales · 29,022 sh · avg $20.43 · $592,812

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-09-09 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −12,886 1,017,711 D
2022-09-12 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −16,136 1,001,575 D
Loading xslF345X03/doc4.xml…